This proposal is a continuation of our research in the development of high performance liquid chromatography (HPLC) to problems of biochemical importance. Our focus in the HPLC of biopolymers, especially proteins, but also including oligonucleotides. The strategy involves a two pronged attack on the problem -- synthesis of bonded phases and examination of the physiochemical phenomena involved. Three separate programs are proposed. (1) First, we shall examine in detail separation based on high performance hydrophobic interaction chromatography, using newly developed stable and reproducible polyether phases. We shall systematically vary the hydrophobic character of the surface, both in terms of extent of hydrophobicity of individual ligands and the spacing between ligands. Of particular interest is the use of phases derived from cholic acid, in which a broad interaction to a relatively rigid group can be envisioned. Adsorption isotherms to explore hysteresis and the kinetics of desorption will also be studied. (2) Secondly, we shall examine metal chelate chromatography using new approaches to ligand binding. This work will involve the role of metal chelate structure, metal and spacing between bonded ligands. Attempts will be made to map the surface topography of complexing amino acids on proteins. (3) A third area will involve a continuation of the study of conformational and other macromolecular behavior in HPLC. Biopolymers which reversibly, e.g., ribonuclease, and irreversibly, e.g., papain, convert from native to denatured states will be studied by various HPLC methods including reversed phase, hydrophobic interaction and size exclusion chromatography. Adsorption on various structurally controlled surfaces will be examined, particularly with a view toward large scale operation.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM015847-18
Application #
3268845
Study Section
(SSS)
Project Start
1978-12-01
Project End
1990-02-28
Budget Start
1987-03-01
Budget End
1988-02-29
Support Year
18
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Northeastern University
Department
Type
Schools of Arts and Sciences
DUNS #
039318308
City
Boston
State
MA
Country
United States
Zip Code
02115
Liu, Zhenke; Dai, Shujia; Bones, Jonathan et al. (2015) A quantitative proteomic analysis of cellular responses to high glucose media in Chinese hamster ovary cells. Biotechnol Prog 31:1026-38
Li, Siyang; Nakayama, Tomoko; Akinc, Akin et al. (2015) Development of LC-MS methods for quantitation of hepcidin and demonstration of siRNA-mediated hepcidin suppression in serum. J Pharmacol Toxicol Methods 71:110-9
Panikov, Nicolai S; Mandalakis, Manolis; Dai, Shujia et al. (2015) Near-zero growth kinetics of Pseudomonas putida deduced from proteomic analysis. Environ Microbiol 17:215-28
Li, Siyang; Plouffe, Brian D; Belov, Arseniy M et al. (2015) An Integrated Platform for Isolation, Processing, and Mass Spectrometry-based Proteomic Profiling of Rare Cells in Whole Blood. Mol Cell Proteomics 14:1672-83
Olsen, Lars; Campos, Benito; Winther, Ole et al. (2014) Tumor antigens as proteogenomic biomarkers in invasive ductal carcinomas. BMC Med Genomics 7 Suppl 3:S2
Brazin, Kristine N; Mallis, Robert J; Li, Chen et al. (2014) Constitutively oxidized CXXC motifs within the CD3 heterodimeric ectodomains of the T cell receptor complex enforce the conformation of juxtaposed segments. J Biol Chem 289:18880-92
Laviolette, Laura A; Wilson, Jonas; Koller, Julia et al. (2013) Human folliculin delays cell cycle progression through late S and G2/M-phases: effect of phosphorylation and tumor associated mutations. PLoS One 8:e66775
Li, Chen; Rossomando, Anthony; Wu, Shiaw-Lin et al. (2013) Comparability analysis of anti-CD20 commercial (rituximab) and RNAi-mediated fucosylated antibodies by two LC-MS approaches. MAbs 5:565-75
Dai, Shujia; Ni, Wenqin; Patananan, Alexander N et al. (2013) Integrated proteomic analysis of major isoaspartyl-containing proteins in the urine of wild type and protein L-isoaspartate O-methyltransferase-deficient mice. Anal Chem 85:2423-30
Tummala, Seshu; Titus, Michael; Wilson, Lee et al. (2013) Evaluation of exogenous siRNA addition as a metabolic engineering tool for modifying biopharmaceuticals. Biotechnol Prog 29:415-24

Showing the most recent 10 out of 47 publications